Sanofi (LON:0O59)

Market Cap	86.53B
Revenue (ttm)	37.78B
Net Income (ttm)	5.27B
Shares Out	n/a
EPS (ttm)	4.22
PE Ratio	16.42
Forward PE	10.04
Dividend	3.30 (4.01%)
Ex-Dividend Date	May 12, 2025

Volume	48,183
Average Volume	749,426
Open	84.78
Previous Close	82.07
Day's Range	83.06 - 83.88
52-Week Range	81.51 - 110.84
Beta	0.41
RSI	39.03
Earnings Date	Jul 31, 2025

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; inf...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 82,878
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0O59

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.

Financial numbers in EUR